The attention around weight loss drugs is a good reminder for employers of the importance of responsible and well-communicated benefit design
Historical or previous (79.787.1%) and recent use (71.2%) of ACEi/ARB was common
Retatrutide efficacy The phase 3 randomised, doubleblind, placebocontrolled TRIUMPH-1 trial evaluated the safety and efficacy of retatrutide for the treatment of patients with obesity or overweight, moderate-to-severe obstructive sleep apnoea and obesity, and knee osteoarthritis pain
Photo by Innerbody Research in addition to their uses in areas like weight loss, immune modulation, and cognitive enhancement, therapeutic peptides have demonstrated high potential to improve physical performance and body composition
Unregistered medicines The products being manufactured were not registered medicines approved by SAHPRA
No physician oversight and no legal recourse if something goes wrong